SCHEMBL13488016

SCHEMBL13488016

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4ccc(-c5cccc6ccccc56)cc34)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
NTSR1 P30989 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487631 0.94 ALDH1A1 (0.36) ALDH1A1MAPTHPGDKDM4ETP53
SCHEMBL13488164 0.92 PDK2 (0.36) ALDH1A1MAPTHPGDKDM4EATM
SCHEMBL13488012 0.92 MEN1 (0.35) ALDH1A1MAPTHPGDKDM4ETP53
SCHEMBL13487928 0.91 PDK2 (0.38) ALDH1A1MAPTHPGDL3MBTL1NTSR1
SCHEMBL10301152 0.90 MEN1 (0.36) ALDH1A1MAPTHPGDKDM4EATM
SCHEMBL18086833 0.90 MEN1 (0.38) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL13488085 0.89 CYP1A2 (0.34) ALDH1A1MAPTHPGDKDM4ETP53
SCHEMBL13487793 0.89 MEN1 (0.35) ALDH1A1MAPTHPGDKDM4EATM
SCHEMBL13488010 0.88 ENPP1 (0.37) ALDH1A1MAPTHPGDKDM4ETP53
SCHEMBL13487983 0.88 HTR2C (0.38) ALDH1A1MAPTHPGDKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALDH1A1 101/4885MAPT 2219/4885HPGD 842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.